|
    BP2M Berlin Stock Exchange

    AIkido Pharma Inc.

    BP2MDE
    Closed
    Back To Top
    Last Updated: May 6, 2021 12:00 a.m. CEDT

    0.76

    -0.03 -3.21%
    Previous Close
    €0.78
    Advanced Charting
    • $
    • %
    • Vol
    Volume: 1K 65 Day Avg: 2.31K
    43% vs Avg
    0.76 Day Range 0.76
    0.43 52 Week Range 2.12

    Your Watchlists

    Customize eLesor

    Have Watchlists? Log in to see them here or sign up to get started.

    Symbol
    Company
    Price
    Chg/Chg %
    No Items in Watchlist

    There are currently no items in this Watchlist.

    Uh oh

    Something went wrong while loading Watchlist.

    Recently Viewed Tickers

    No Recent Tickers

    Visit a quote page and your recently viewed tickers will be displayed here.

    BP2M Overview

    Performance

    5 Day
    • -11.70%
    1 Month
    • -17.49%
    3 Month
    • -40.55%
    YTD
    • 43.81%
    1 Year
    • 10.22%

    Recent News

    • eLesor
    • Dow Jones

    No Headlines Available

    • Other News
    • Press Releases

    No Headlines Available

    AIkido Pharma Inc.

    AIkido Pharma, Inc. is a biotechnology development company, which engages in the provision of diversified portfolio of small-molecule anticancer and antiviral therapeutics in development. Its oncology therapeutics includes treatments for pancreatic cancer, acute myeloid leukemia, and acute lymphoblastic leukemia. It also creates broad-spectrum antiviral platform, in which the lead compounds have activity against multiple viruses including Influenza virus, Ebolavirus and Marburg virus, SARS-CoV, MERS-CoV, and SARS-CoV-2, the cause of COVID-19. The company was founded by Gilbert V. Levin and M. Karen Levin in 1967 and is headquartered in New York, NY.